Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse

Online download statistics by month:

Online download statistics by month: January 2018 to May 2023

	Abstract	Full	Pdf
Jan 2018	269	14	12
Feb 2018	618	40	18
Mar 2018	199	36	10
Apr 2018	70	27	13
May 2018	131	24	12
Jun 2018	78	25	6
Jul 2018	48	20	1
Aug 2018	70	23	7
Sep 2018	93	28	11
Oct 2018	259	36	26
Nov 2018	333	63	37
Dec 2018	190	49	17
Jan 2019	135	28	9
Feb 2019	80	24	8
Mar 2019	54	9	12
Apr 2019	35	5	2
May 2019	58	10	3
Jun 2019	84	26	11
Jul 2019	95	18	6
Aug 2019	57	18	6
Sep 2019	64	16	3
Oct 2019	38	18	4
Nov 2019	64	23	3
Dec 2019	90	32	5
Jan 2020	52	23	5
Feb 2020	68	19	3
Mar 2020	78	34	11
Apr 2020	83	37	12
May 2020	68	37	6
Jun 2020	58	26	3
Jul 2020	68	27	2
Aug 2020	36	19	5
Sep 2020	81	30	6
Oct 2020	84	28	4
Nov 2020	35	6	4
Dec 2020	98	2	5
Jan 2021	64	10	14
Feb 2021	58	3	4
Mar 2021	32	5	4
Apr 2021	27	1	3
May 2021	29	0	0
Jun 2021	2	1	0
Jul 2021	5	4	4
Aug 2021	2	2	3
Sep 2021	6	2	0
Oct 2021	54	7	4
Nov 2021	25	4	2
Dec 2021	83	4	2
Jan 2022	57	6	8
Feb 2022	25	4	1
Mar 2022	46	1	0
Apr 2022	28	2	3
May 2022	86	5	3
Jun 2022	48	4	1
Jul 2022	46	4	1
Aug 2022	63	5	0
Sep 2022	47	1	2
Oct 2022	89	10	10
Nov 2022	67	5	3
Dec 2022	28	2	1
Jan 2023	23	2	1
Feb 2023	82	1	1
Mar 2023	25	4	0
Apr 2023	54	0	1
May 2023	33	4	3
Total	5255	1003	387